AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Jul 9, 2020
29821_dirs_2020-07-06_65d4ec30-1db8-4d2a-8c56-018d86e015ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-07-01
Reporting Person: Monson Jonathan (VP, Corp Controller and CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-01 | Common Stock | M | 728.0000 | $0.0000 | Acquired | 34601.0000 | Direct |
| 2020-07-01 | Common Stock | F | 221.0000 | $35.2800 | Disposed | 34380.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-01 | Deferred Stock Units | $ | M | 728.0000 | Disposed | 2023-07-01 | Common Stock (728.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 2